Regulus Therapeutics said that it has named Garry Menzel as executive vice president of corporate development and finance.
Menzel previously served as managing director for Credit Suisse. Before that, he was a managing director of Goldman Sachs’ healthcare group. He holds a PhD in molecular biology from the University of Cambridge and an MBA from the Stanford Graduate School of Business.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.
Try GenomeWeb Premium now.
Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
